Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» October 2010
October 2010
Brand-Name Drugmakers Not Liable For Generics
Brand-Name Drugmakers Not Liable For Generics
Pharmalot
generics
Wyeth
Pfizer
Reglan
Schwarz
The 3 Words Every Biotech Investor Wants to Hear
The 3 Words Every Biotech Investor Wants to Hear
Motley Fool
biotech
Acorda Therapeutics
Elan
JNJ
Biogen Idec
United Therapeutics earnings triple to $39.7M
United Therapeutics earnings triple to $39.7M
Bizjournals.com
earnings
United Therapeutics
Novartis Wins Challenge Against J&J Over Its French Contact Lens Patent
Novartis Wins Challenge Against J&J Over Its French Contact Lens Patent
Bloomberg
France
JNJ
Novartis
patents
contact lens
Keryx Biopharm: A Promising Long Term Pick
Keryx Biopharm: A Promising Long Term Pick
Seeking Alpha
Keryx
Zerenex
NJ's Savient plans to handle launch of new gout drug on its own
NJ's Savient plans to handle launch of new gout drug on its own
Newark Star-Ledger, NJ
Savient
gout
Krystexxa
Sanofi’s Viehbacher Rules Out $80-a-Share Offer for Genzyme
Sanofi’s Viehbacher Rules Out $80-a-Share Offer for Genzyme
Bloomberg
Genzyme
Sanofi
Chris Viehbacher
M&A
AstraZeneca Q3 profit down 27 pct amid legal costs
AstraZeneca Q3 profit down 27 pct amid legal costs
Yahoo/AP
earnings
AstraZeneca
Sanofi-Aventis Earnings Jump 13%
Sanofi-Aventis Earnings Jump 13%
TheStreet.com
earnings
Sanofi
Biotech ETFs Up As Biogen, Illumina, Amylin Soar
Biotech ETFs Up As Biogen, Illumina, Amylin Soar
Barron's
Biogen Idec
Amylin
Illumina
ETFs
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »